Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Type B adverse drug reactions reported by an immunoallergology department.

Costa MJ, Herdeiro MT, Polónia JJ, Ribeiro-Vaz I, Botelho C, Castro E, Cernadas J.

Pharm Pract (Granada). 2018 Jan-Mar;16(1):1070. doi: 10.18549/PharmPract.2018.01.1070. Epub 2018 Mar 21.

2.

The effects of distraction on symptoms during drug provocation test.

Cildag S, Senturk T, Sargin G.

Clujul Med. 2017;90(1):18-21. doi: 10.15386/cjmed-688. Epub 2017 Jan 15.

3.

Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.

Kowalski ML, Ansotegui I, Aberer W, Al-Ahmad M, Akdis M, Ballmer-Weber BK, Beyer K, Blanca M, Brown S, Bunnag C, Hulett AC, Castells M, Chng HH, De Blay F, Ebisawa M, Fineman S, Golden DB, Haahtela T, Kaliner M, Katelaris C, Lee BW, Makowska J, Muller U, Mullol J, Oppenheimer J, Park HS, Parkerson J, Passalacqua G, Pawankar R, Renz H, Rueff F, Sanchez-Borges M, Sastre J, Scadding G, Sicherer S, Tantilipikorn P, Tracy J, van Kempen V, Bohle B, Canonica GW, Caraballo L, Gomez M, Ito K, Jensen-Jarolim E, Larche M, Melioli G, Poulsen LK, Valenta R, Zuberbier T.

World Allergy Organ J. 2016 Oct 12;9(1):33. eCollection 2016. Erratum in: World Allergy Organ J. 2017 Jan 11;10 (1):6.

4.

In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells.

Galbiati V, Papale A, Kummer E, Corsini E.

Front Pharmacol. 2016 Jul 12;7:204. doi: 10.3389/fphar.2016.00204. eCollection 2016. Review.

5.

More than skin deep. Ten year follow-up of delayed cutaneous adverse drug reactions (CADR).

Graudins LV, Ly J, Trubiano J, Aung AK.

Br J Clin Pharmacol. 2016 Oct;82(4):1040-7. doi: 10.1111/bcp.13030. Epub 2016 Jul 18.

6.

Knowledge, attitudes, and practices survey of drug allergy among healthcare practitioners in central China: a multicenter study.

Wang Y, Zhu R, Huang N, Li W, Yang L, Zhang S, Liu G.

Asia Pac Allergy. 2016 Apr;6(2):105-11. doi: 10.5415/apallergy.2016.6.2.105. Epub 2016 Apr 28.

7.

Approach to drug allergies in the childhood.

Yazıcıoğlu M.

Turk Pediatri Ars. 2014 Jun 1;49(2):99-103. doi: 10.5152/tpa.2014.1944. eCollection 2014 Jun. Review.

8.

Multiple drug intolerance syndrome: a large-scale retrospective study.

Omer HM, Hodson J, Thomas SK, Coleman JJ.

Drug Saf. 2014 Dec;37(12):1037-45. doi: 10.1007/s40264-014-0236-x.

9.

Approaches to recording drug allergies in electronic health records: qualitative study.

Fernando B, Morrison Z, Kalra D, Cresswell K, Sheikh A.

PLoS One. 2014 Apr 16;9(4):e93047. doi: 10.1371/journal.pone.0093047. eCollection 2014.

10.

Topical promethazine side effects: our experience and review of the literature.

Cantisani C, Ricci S, Grieco T, Paolino G, Faina V, Silvestri E, Calvieri S.

Biomed Res Int. 2013;2013:151509. doi: 10.1155/2013/151509. Epub 2013 Nov 19. Review.

11.

β-lactam allergy: clinical implications and costs.

Satta G, Hill V, Lanzman M, Balakrishnan I.

Clin Mol Allergy. 2013 Nov 27;11(1):2. doi: 10.1186/1476-7961-11-2.

12.

Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.

Sánchez-Borges M, Thong B, Blanca M, Ensina LF, González-Díaz S, Greenberger PA, Jares E, Jee YK, Kase-Tanno L, Khan D, Park JW, Pichler W, Romano A, Jaén MJ.

World Allergy Organ J. 2013 Oct 31;6(1):18. doi: 10.1186/1939-4551-6-18.

13.

Drug provocation tests: up-date and novel approaches.

Chiriac AM, Demoly P.

Allergy Asthma Clin Immunol. 2013 Apr 3;9(1):12. doi: 10.1186/1710-1492-9-12.

14.

Adverse drug reaction, patent blue V dye and anaesthesia.

Tripathy S, Nair PV.

Indian J Anaesth. 2012 Nov;56(6):563-6. doi: 10.4103/0019-5049.104576.

15.

World allergy organization guidelines for the assessment and management of anaphylaxis.

Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY; World Allergy Organization.

World Allergy Organ J. 2011 Feb;4(2):13-37. doi: 10.1097/WOX.0b013e318211496c. Epub 2011 Feb 23.

16.

A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity.

Thong BY, Mirakian R, Castells M, Pichler W, Romano A, Bonadonna P, Diana D, Kowalski M, Yanez A, Lleonart R, Sanchez-Borges M, Demoly P.

World Allergy Organ J. 2011 Dec;4(12):257-70. doi: 10.1097/WOX.0b013e31823dc02c. Epub 2011 Dec 14.

17.

Anaphylaxis triggered by benzyl benzoate in a preparation of depot testosterone undecanoate.

Ong GS, Somerville CP, Jones TW, Walsh JP.

Case Rep Med. 2012;2012:384054. doi: 10.1155/2012/384054. Epub 2012 Jan 5.

18.

Drug allergy.

Warrington R, Silviu-Dan F.

Allergy Asthma Clin Immunol. 2011 Nov 10;7 Suppl 1:S10. doi: 10.1186/1710-1492-7-S1-S10.

19.

Usefulness of drug provocation tests in children with a history of adverse drug reaction.

Na HR, Lee JM, Jung JW, Lee SY.

Korean J Pediatr. 2011 Jul;54(7):304-9. doi: 10.3345/kjp.2011.54.7.304. Epub 2011 Jul 31.

20.

General principles of investigating and managing drug allergy.

Frew A.

Br J Clin Pharmacol. 2011 May;71(5):642-6. doi: 10.1111/j.1365-2125.2011.03933.x. Review.

Supplemental Content

Support Center